R. L. Siegel, K. D. Miller, and A. Jemal, Cancer Statistics, CA Cancer J Clin, vol.67, pp.7-30, 2017.

J. A. Ledermann, F. A. Raja, C. Fotopoulou, A. Gonzalezmartin, N. Colombo et al., Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, vol.24, issue.6, pp.24-32, 2013.

D. Hanahan and R. A. Weinberg, Hallmarks of cancer: the next generation, Cell, vol.144, pp.646-74, 2011.

P. Juin, O. Geneste, F. Gautier, S. Depil, and M. Campone, Decoding and unlocking the BCL-2 dependency of cancer cells, Nat Rev Cancer, vol.13, pp.455-65, 2013.

C. Gloaguen, A. S. Voisin-chiret, J. Sopkova-de-oliveira-santos, J. Fogha, F. Gautier et al., First evidence that oligopyridines, ?-helix foldamers, inhibit Mcl-1 and sensitize ovarian carcinoma cells to Bcl-xL-targeting strategies, J Med Chem, vol.58, pp.1644-68, 2015.

K. Simonin, N. 'diaye, M. Lheureux, S. Loussouarn, C. Dutoit et al., Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis, Apoptosis, vol.18, pp.492-508, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00872602

E. Brotin, M. Meryet-figuière, K. Simonin, R. E. Duval, M. Villedieu et al., Bcl-XL and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis, Int J Cancer, vol.126, pp.885-95, 2010.

L. Kassem and O. Abdel-rahman, Targeting mTOR pathway in gynecological malignancies: biological rationale and systematic review of published data, Crit Rev Oncol Hematol, vol.108, pp.1-12, 2016.

S. Mabuchi, H. Kuroda, R. Takahashi, and T. Sasano, The PI3K/ AKT/mTOR pathway as a therapeutic target in ovarian cancer, Sci Transl Med, vol.137, pp.369-175, 2015.

A. C. Faber, D. Li, Y. Song, M. C. Liang, B. Y. Yeap et al., Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition, Proc Natl Acad Sci USA, vol.106, pp.19503-19511, 2009.

A. Jebahi, M. Villedieu, C. Pétigny-lechartier, E. Brotin, M. H. Louis et al., PI3K/mTOR dual inhibitor NVP-BEZ235 decreases Mcl-1 expression and sensitizes ovarian carcinoma cells to Bcl-xL-targeting strategies, provided that Bim expression is induced, Cancer Lett, vol.348, pp.38-49, 2014.

I. K. Zervantonakis, C. Iavarone, H. Y. Chen, L. M. Selfors, S. Palakurthi et al., Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response, Nat Commun, vol.8, p.365, 2017.

M. J. Berridge, P. Lipp, and M. D. Bootman, The versatility and universality of calcium signalling, Nat Rev Mol Cell Biol, vol.1, pp.11-21, 2000.

N. Prevarskaya, H. Ouadid-ahidouch, R. Skryma, and Y. Shuba, Remodelling of Ca2+ transport in cancer: how it contributes to cancer hallmarks?, Philos Trans R Soc Lond B Biol Sci, vol.369, 2014.

C. Cui, R. Merritt, L. Fu, and Z. Pan, Targeting calcium signaling in cancer therapy, Acta Pharm Sin B, vol.7, pp.3-17, 2017.

G. R. Monteith, N. Prevarskaya, and S. J. Roberts-thomson, The calcium-cancer signalling nexus, Nat Rev Cancer, vol.17, pp.367-80, 2017.

G. R. Monteith, F. M. Davis, and S. J. Roberts-thomson, Calcium channels and pumps in cancer: changes and consequences, J Biol Chem, vol.287, pp.31666-73, 2012.

N. Prevarskaya, R. Skryma, and Y. Shuba, Targeting Ca² + transport in cancer: close reality or long perspective?, Expert Opin Ther Targets, vol.17, pp.225-266, 2013.

N. M. Conus, B. A. Hemmings, and R. B. Pearson, Differential regulation by calcium reveals distinct signaling requirements for the activation of Akt and p70S6k, J Biol Chem, vol.273, pp.4776-82, 1998.

K. M. Hannan, G. Thomas, and R. B. Pearson, Activation of S6K1 (p70 ribosomal protein S6 kinase 1) requires an initial calcium-dependent priming event involving formation of a high-molecular-mass signalling complex, Biochem J, vol.370, pp.469-77, 2003.

L. M. Graves, Y. He, J. Lambert, D. Hunter, X. Li et al., An intracellular calcium signal activates p70 but not p90 ribosomal S6 kinase in liver epithelial cells, J Biol Chem, vol.272, pp.1920-1948, 1997.

P. Gulati, L. D. Gaspers, S. G. Dann, J. M. Nobukuni, T. Natt et al., Amino acids activate mTOR complex 1 via Ca2+/CaM signaling to hVps34, Cell Metab, vol.7, pp.456-65, 2008.

F. Mercan, H. Lee, S. Kolli, and A. M. Bennett, Novel role for SHP-2 in nutrient-responsive control of S6 kinase 1 signaling, Mol Cell Biol, vol.33, pp.293-306, 2013.

X. Zhou, D. S. Lin, F. Zheng, M. A. Sutton, and H. Wang, Intracellular calcium and calmodulin link brain-derived neurotrophic factor to p70S6 kinase phosphorylation and dendritic protein synthesis, J Neurosci Res, vol.88, pp.1420-1452, 2010.

Z. Ke, D. Liang, Q. Zeng, Q. Ren, H. Ma et al., hsBAFF promotes proliferation and survival in cultured B lymphocytes via calcium signaling activation of mTOR pathway, Cytokine, vol.62, pp.310-331, 2013.

R. J. Li, J. Xu, C. Fu, J. Zhang, Y. G. Zheng et al., Regulation of mTORC1 by lysosomal calcium and calmodulin, eLife, vol.5, p.5, 2016.

S. Antoniotti, F. Pla, A. Pregnolato, S. Mottola, A. Lovisolo et al., Control of endothelial cell proliferation by calcium influx and arachidonic acid metabolism: a pharmacological approach, J Cell Physiol, vol.197, pp.370-78, 2003.

M. D'amato, A. M. Flugy, G. Alaimo, B. Bauder, E. C. Kohn et al., Role of calcium in E-selectin induced phenotype of T84 colon carcinoma cells, Biochem Biophys Res Commun, vol.301, pp.907-921, 2003.

M. Faehling, J. Kroll, K. J. Föhr, G. Fellbrich, U. Mayr et al., Essential role of calcium in vascular endothelial growth factor A-induced signaling: mechanism of the antiangiogenic effect of carboxyamidotriazole, FASEB J, vol.16, pp.1805-1812, 2002.

F. Pla, A. Grange, C. Antoniotti, S. Tomatis, C. Merlino et al., Arachidonic acid-induced Ca2+ entry is involved in early steps of tumor angiogenesis, Mol Cancer Res, vol.6, pp.535-580, 2008.

T. W. Moody, J. Chiles, E. Moody, G. J. Sieczkiewicz, and E. C. Kohn, CAI inhibits the growth of small cell lung cancer cells, Lung Cancer, vol.39, pp.279-88, 2003.

Y. Wu, A. J. Palad, W. J. Wasilenko, P. F. Blackmore, W. A. Pincus et al., Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole, Clin Cancer Res, vol.3, pp.1915-1936, 1997.

A. Enfissi, S. Prigent, P. Colosetti, and T. Capiod, The blocking of capacitative calcium entry by 2-aminoethyl diphenylborate (2-APB) and carboxyamidotriazole (CAI) inhibits proliferation in Hep G2 and Huh-7 human hepatoma cells, Cell Calcium, vol.36, pp.459-67, 2004.

F. Lodola, U. Laforenza, E. Bonetti, D. Lim, S. Dragoni et al., Storeoperated Ca2+ entry is remodelled and controls in vitro angiogenesis in endothelial progenitor cells isolated from tumoral patients, PLoS One, vol.7, p.42541, 2012.

O. Mignen, C. Brink, A. Enfissi, A. Nadkarni, T. J. Shuttleworth et al., Carboxyamidotriazole-induced www.oncotarget.com inhibition of mitochondrial calcium import blocks capacitative calcium entry and cell proliferation in HEK-293 cells, J Cell Sci, vol.118, pp.5615-5638, 2005.

N. Azad, A. Perroy, E. Gardner, C. K. Imamura, C. Graves et al., A phase I study of paclitaxel and continuous daily CAI in patients with refractory solid tumors, Cancer Biol Ther, vol.8, pp.1800-1805, 2009.

K. S. Bauer, W. D. Figg, J. M. Hamilton, E. C. Jones, A. Premkumar et al., A pharmacokinetically guided Phase II study of carboxyamido-triazole in androgen-independent prostate cancer, Clin Cancer Res, vol.5, pp.2324-2353, 1999.

J. Berlin, K. D. Tutsch, R. Z. Arzoomanian, D. Alberti, K. Binger et al., Phase I and pharmacokinetic study of a micronized formulation of carboxyamidotriazole, a calcium signal transduction inhibitor: toxicity, bioavailability and the effect of food, Clin Cancer Res, vol.8, pp.86-94, 2002.

J. P. Dutcher, L. Leon, J. Manola, D. M. Friedland, B. Roth et al., Phase II study of carboxyamidotriazole in patients with advanced renal cell carcinoma refractory to immunotherapy: E4896, an Eastern Cooperative Oncology Group Study, Cancer, vol.104, pp.2392-99, 2005.

M. M. Hussain, H. Kotz, L. Minasian, A. Premkumar, G. Sarosy et al., Phase II trial of carboxyamidotriazole in patients with relapsed epithelial ovarian cancer, J Clin Oncol, vol.21, pp.4356-63, 2003.

E. C. Kohn, E. Reed, G. Sarosy, M. Christian, C. J. Link et al., Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers, Cancer Res, vol.56, pp.569-73, 1996.

E. C. Kohn, E. Reed, G. A. Sarosy, L. Minasian, K. S. Bauer et al., A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: potential efficacy of the combination and demonstration of pharmacokinetic interaction, Clin Cancer Res, vol.7, pp.1600-1609, 2001.

A. Omuro, K. Beal, K. Mcneill, R. J. Young, A. Thomas et al., Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas, J Clin Oncol, vol.36, pp.1702-1711, 2018.

L. W. Thomas, C. Lam, and S. W. Edwards, Mcl-1; the molecular regulation of protein function, FEBS Lett, vol.584, pp.2981-89, 2010.

G. S. Bird, W. I. Dehaven, J. T. Smyth, and J. W. Putney, Methods for studying store-operated calcium entry, Methods, vol.46, pp.204-216, 2008.

I. Jardin and J. A. Rosado, STIM and calcium channel complexes in cancer, Biochim Biophys Acta, vol.1863, pp.1418-1444, 2016.

J. Lytton, M. Westlin, and M. R. Hanley, Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps, J Biol Chem, vol.266, pp.17067-71, 1991.

M. Breuleux, M. Klopfenstein, C. Stephan, C. A. Doughty, L. Barys et al., Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition, Mol Cancer Ther, vol.8, pp.742-53, 2009.

M. Laplante and D. M. Sabatini, mTOR signaling in growth control and disease, Cell, vol.149, pp.274-93, 2012.

Z. Jing, X. Sui, J. Yao, J. Xie, L. Jiang et al., SKF-96365 activates cytoprotective autophagy to delay apoptosis in colorectal cancer cells through inhibition of the calcium/CaMKII?/AKT-mediated pathway, Cancer Lett, vol.372, pp.226-264, 2016.

Y. Y. Wang, R. Zhao, and H. Zhe, The emerging role of CaMKII in cancer, Oncotarget, vol.6, pp.11725-11734, 2015.

M. M. Mihaylova and R. J. Shaw, The AMPK signalling pathway coordinates cell growth, autophagy and metabolism, Nat Cell Biol, vol.13, pp.1016-1039, 2011.

J. Ishikawa, K. Ohga, T. Yoshino, R. Takezawa, A. Ichikawa et al., A pyrazole derivative, YM-58483, potently inhibits store-operated sustained Ca2+ influx and IL-2 production in T lymphocytes, J Immunol, vol.170, pp.4441-4490, 2003.

S. Chen, Y. Dai, H. Harada, P. Dent, and S. Grant, Mcl-1 downregulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation, Cancer Res, vol.67, pp.782-91, 2007.

K. M. Lucas, N. Mohana-kumaran, D. Lau, X. D. Zhang, P. Hersey et al., Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737, Clin Cancer Res, vol.18, pp.783-95, 2012.

A. R. Fontana, S. Giordano, M. Corrado, C. Colomba, P. Flugy et al., Effects of carboxyamidotriazole on in vitro models of imatinibresistant chronic myeloid leukemia, J Cell Physiol, vol.215, pp.111-132, 2008.

P. A. Lambert, K. D. Somers, E. C. Kohn, and R. R. Perry, Antiproliferative and antiinvasive effects of carboxyamidotriazole on breast cancer cell lines, Surgery, vol.122, pp.372-78, 1997.

C. Chen, R. Ju, J. Shi, W. Chen, F. Sun et al., Carboxyamidotriazole Synergizes with Sorafenib to Combat Non-Small Cell Lung Cancer through Inhibition of NANOG and Aggravation of Apoptosis, J Pharmacol Exp Ther, vol.362, pp.219-248, 2017.

L. Guo, Z. S. Li, H. L. Wang, C. Y. Ye, and D. C. Zhang, Carboxyamidotriazole inhibits proliferation of human breast cancer cells www.oncotarget.com via G(2)/M cell cycle arrest and apoptosis, Eur J Pharmacol, vol.538, pp.15-22, 2006.

J. L. Yang, X. J. Qu, Y. Yu, E. C. Kohn, and M. L. Friedlander, Selective sensitivity to carboxyamidotriazole by human tumor cell lines with DNA mismatch repair deficiency, Int J Cancer, vol.123, pp.258-63, 2008.

S. Ge, S. A. Rempel, G. Divine, and T. Mikkelsen, Carboxyamidotriazole induces apoptosis in bovine aortic endothelial and human glioma cells, Clin Cancer Res, vol.6, pp.1248-54, 2000.

K. D. Rodland, R. P. Wersto, S. Hobson, and E. C. Kohn, Thapsigargin-induced gene expression in nonexcitable cells is dependent on calcium influx, Mol Endocrinol, vol.11, pp.281-91, 1997.

A. M. Gocher, G. Azabdaftari, L. M. Euscher, S. Dai, L. G. Karacosta et al., Akt activation by Ca2+/ calmodulin-dependent protein kinase kinase 2 (CaMKK2) in ovarian cancer cells, J Biol Chem, vol.292, pp.14188-204, 2017.

M. Høyer-hansen and M. Jäättelä, AMP-activated protein kinase: a universal regulator of autophagy?, Autophagy, vol.3, pp.381-83, 2007.

J. Yang, J. Yu, D. Li, S. Yu, J. Ke et al., Store-operated calcium entry-activated autophagy protects EPC proliferation via the CAMKK2-MTOR pathway in ox-LDL exposure, Autophagy, vol.13, pp.82-98, 2017.

K. D. Kim, S. Srikanth, M. K. Yee, D. C. Mock, G. W. Lawson et al., ORAI1 deficiency impairs activated T cell death and enhances T cell survival, J Immunol, vol.187, pp.3620-3650, 2011.

T. Hewavitharana, X. Deng, Y. Wang, M. F. Ritchie, G. V. Girish et al., Location and function of STIM1 in the activation of Ca2+ entry signals, J Biol Chem, vol.283, pp.26252-62, 2008.

N. Yang, Y. Tang, F. Wang, H. Zhang, D. Xu et al., Blockade of store-operated Ca(2+) entry inhibits hepatocarcinoma cell migration and invasion by regulating focal adhesion turnover, Cancer Lett, vol.330, pp.163-69, 2013.

B. D. Tang, X. Xia, X. F. Lv, B. X. Yu, J. N. Yuan et al., Inhibition of Orai1-mediated Ca 2+ entry enhances chemosensitivity of HepG2 hepatocarcinoma cells to 5-fluorouracil, J Cell Mol Med, vol.21, pp.904-919, 2017.

R. K. Motiani, M. C. Hyzinski-garcía, X. Zhang, M. M. Henkel, I. F. Abdullaev et al., STIM1 and Orai1 mediate CRAC channel activity and are essential for human glioblastoma invasion, Pflugers Arch, vol.465, pp.1249-60, 2013.

S. Yang, J. J. Zhang, and X. Y. Huang, Orai1 and STIM1 are critical for breast tumor cell migration and metastasis, Cancer Cell, vol.15, pp.124-158, 2009.

Y. F. Chen, W. T. Chiu, Y. T. Chen, P. Y. Lin, H. J. Huang et al., Calcium store sensor stromal-interaction molecule 1-dependent signaling plays an important role in cervical cancer growth, migration, and angiogenesis, Proc Natl Acad Sci USA, vol.108, pp.15225-15255, 2011.

S. Schmidt, G. Liu, G. Liu, W. Yang, S. Honisch et al., Enhanced Orai1 and STIM1 expression as well as store operated Ca2+ entry in therapy resistant ovary carcinoma cells, Oncotarget, vol.5, pp.4799-810, 2014.

M. E. Winters, A. I. Mehta, E. C. Kohn, and L. A. Liotta, Supra-additive growth inhibition by a celecoxib analogue and carboxyamido-triazole is primarily mediated through apoptosis, Cancer Res, vol.65, pp.3853-60, 2005.

R. Ju, L. Guo, J. Li, L. Zhu, X. Yu et al., Carboxyamidotriazole inhibits oxidative phosphorylation in cancer cells and exerts synergistic anticancer effect with glycolysis inhibition, Cancer Lett, vol.370, pp.232-273, 2016.

F. Lesept, A. Chevilley, J. Jezequel, L. Ladépêche, R. Macrez et al., Tissue-type plasminogen activator controls neuronal death by raising surface dynamics of extrasynaptic NMDA receptors, Cell Death Dis, vol.7, p.2466, 2016.